HCPCS Level IIdrugActive
J0737
Inj, clindamycin (baxter)
BETOS: O1E
Effective: 2024-01-01
Description
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Clindamycin Phosphate
Manufacturer
Baxter Healthcare Corporation
HCPCS Dosage
300 MG
Billing Units
1.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.